☆ 4.7 Article

Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study

JOURNAL OF AUTOIMMUNITY (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Rheumatology

Predictors of hypogammaglobulinemia in ANCA-associated vasculitis after a rituximab-based induction: a multicentre study

Manuel Alfredo Podesta et al.

Summary: This study aims to assess factors associated with hypogammaglobulinemia in AAV patients treated with rituximab, and the results showed that hypogammaglobulinemia is common in AAV patients treated with rituximab, and lower IgG levels are associated with severe infections. Age and higher glucocorticoid doses increase the risk of hypogammaglobulinemia in these patients.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis

Joanna C. Robson et al.

Summary: The study aimed to develop and validate revised classification criteria for granulomatosis with polyangiitis (GPA). Through consensus methodology and data analysis, 10 criteria items were identified and assigned weights for GPA diagnosis. The criteria demonstrated high sensitivity and specificity in the validation set, making them suitable for research purposes.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Rheumatology

2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis

Ravi Suppiah et al.

Summary: The study developed and validated classification criteria for microscopic polyangiitis (MPA), with 6 key items identified for disease classification. Validation results showed high sensitivity (91%) and specificity (94%) for the criteria, confirming their usefulness in clinical research.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Biochemical Research Methods

Acquired B-cell deficiency secondary to B-cell-depleting therapies

Annaliesse Blincoe et al.

Summary: The advantage of newer biological therapies lies in their targeted immunosuppressive effect compared to traditional immunomodulatory agents. However, unintended consequences can still occur, leading to acquired immunodeficiency. One specific consequence is B-cell immunodeficiency caused by B-cell depleting therapeutic agents, which can result in hypogammaglobulinemia, impaired B-cell differentiation, and increased risk of infections.

JOURNAL OF IMMUNOLOGICAL METHODS (2022)

添加到收藏夹

Article Rheumatology

Rituximab-associated hypogammaglobulinemia in ANCA-associated vasculitis: Incidence and time course

Anam Tariq et al.

Summary: Hypo-IgG is common among AAV patients treated with RTX, occurring in 42% of patients in this single-center cohort. The nadir IgG levels occur during remission induction, and the IgG levels remain relatively stable or increase over time in those receiving RTX for remission maintenance.

EUROPEAN JOURNAL OF RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

New-onset hypogammaglobulinaemia and infectious complications associated with rituximab use in childhood-onset rheumatic diseases

Mei Sing Ong et al.

Summary: Rituximab treatment for childhood-onset rheumatic diseases can lead to hypogammaglobulinaemia and infectious complications, with steroid therapy and age as significant risk factors.

RHEUMATOLOGY (2022)

添加到收藏夹

Article Rheumatology

Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study

Jens Rathmann et al.

Summary: Severe infection is common in patients with ANCA-associated vasculitis, with predictors including older age and high disease activity at diagnosis. Severe infections are associated with permanent organ damage and high mortality rates.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Immunology

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease

Joanna Tieu et al.

Summary: The study found that patients with autoimmune disease may develop hypogammaglobulinemia following RTX treatment, with this condition persisting during long-term follow-up. Patients with prior exposure to cyclophosphamide, glucocorticoid use at 12 months post-RTX, lower nadir IgG levels within 12 months of RTX initiation, and female sex were more likely to develop moderate hypogammaglobulinemia and/or require immunoglobulin replacement therapy at 60 months post-treatment.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Michael Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Urology & Nephrology

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study

Dimitrios Chanouzas et al.

BMC NEPHROLOGY (2019)

添加到收藏夹

Article Immunology

The effect of pulse methylprednisolone induction therapy in Chinese patients with dialysis-dependent MPO-ANCA associated vasculitis

Li Huang et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2019)

添加到收藏夹

Review Immunology

Consequences of B-cell-depleting therapy: hypogammaglobulinemia and impaired B-cell reconstitution

Keith A. Sacco et al.

IMMUNOTHERAPY (2018)

添加到收藏夹

Article Rheumatology

Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides

Benjamin Terrier et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

添加到收藏夹

Review Immunology

Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab

Evangelos A. A. Christou et al.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2017)

添加到收藏夹

Article Urology & Nephrology

The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study

Yanhong Ma et al.

BMC NEPHROLOGY (2017)

添加到收藏夹

Article Medicine, General & Internal

Low-dose glucocorticoids plus rituximab versus high-dose glucocorticoids plus rituximab for remission induction in ANCA-associated vasculitis (LoVAS): protocol for a multicentre, open-label, randomised controlled trial

Shunsuke Furuta et al.

BMJ OPEN (2017)

添加到收藏夹

Article Rheumatology

Effect of Continuous B Cell Depletion With Rituximab on Pathogenic Autoantibodies and Total IgG Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Frank B. Cortazar et al.

ARTHRITIS & RHEUMATOLOGY (2017)

添加到收藏夹

Article Immunology

Secondary Antibody Deficiency in Glucocorticoid Therapy Clearly Differs from Primary Antibody Deficiency

Clemens Wirsum et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2016)

添加到收藏夹

Editorial Material Allergy

International Consensus Document (ICON): Common Variable Immunodeficiency Disorders

Francisco A. Bonilla et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)

添加到收藏夹

Article Immunology

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Darren M. Roberts et al.

JOURNAL OF AUTOIMMUNITY (2015)

添加到收藏夹

Article Orthopedics

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease

Helena Marco et al.

BMC MUSCULOSKELETAL DISORDERS (2014)

添加到收藏夹

Article Medicine, General & Internal

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

L. Guillevin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

添加到收藏夹

Article Rheumatology

Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis

Emilio Besada et al.

RHEUMATOLOGY (2014)

添加到收藏夹

Article Rheumatology

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

J. C. Jennette et al.

ARTHRITIS AND RHEUMATISM (2013)

添加到收藏夹

Article Medicine, General & Internal

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

Ulrich Specks et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Rheumatology

Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's) Ten-year experience at a single center

Rodrigo Cartin-Ceba et al.

ARTHRITIS AND RHEUMATISM (2012)

添加到收藏夹

Article Rheumatology

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis

Gunnar Tomasson et al.

RHEUMATOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.

John H. Stone et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.